CGA and B-cell chronic lymphocytic leukemia: This dose, when given i.p., generates peak plasma levels of about 3-4 nM CgA that progressively declines to 0.5-1 nM in 7-8 h, as measured by ELISA, i.e. levels similar to those found in CLL patients.